ATE426168T1 - Verwendung von asc als marker fur kolorektalkarzinome - Google Patents

Verwendung von asc als marker fur kolorektalkarzinome

Info

Publication number
ATE426168T1
ATE426168T1 AT05820046T AT05820046T ATE426168T1 AT E426168 T1 ATE426168 T1 AT E426168T1 AT 05820046 T AT05820046 T AT 05820046T AT 05820046 T AT05820046 T AT 05820046T AT E426168 T1 ATE426168 T1 AT E426168T1
Authority
AT
Austria
Prior art keywords
asc
diagnosis
colorectal cancer
marker
colorectal carcinoma
Prior art date
Application number
AT05820046T
Other languages
English (en)
Inventor
Herbert Andres
Marie-Luise Hagmann
Johann Karl
Ursula Kunert
Gabriele Pestlin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE426168T1 publication Critical patent/ATE426168T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05820046T 2004-12-23 2005-12-22 Verwendung von asc als marker fur kolorektalkarzinome ATE426168T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030619 2004-12-23
EP05008660 2005-04-20

Publications (1)

Publication Number Publication Date
ATE426168T1 true ATE426168T1 (de) 2009-04-15

Family

ID=35682429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05820046T ATE426168T1 (de) 2004-12-23 2005-12-22 Verwendung von asc als marker fur kolorektalkarzinome

Country Status (8)

Country Link
US (1) US7846653B2 (de)
EP (1) EP1831696B1 (de)
JP (1) JP4673895B2 (de)
AT (1) ATE426168T1 (de)
CA (1) CA2586654C (de)
DE (1) DE602005013430D1 (de)
ES (1) ES2323429T3 (de)
WO (1) WO2006066917A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323429T3 (es) 2004-12-23 2009-07-15 F. Hoffmann-La Roche Ag Uso de la asc, como marcador para cancer colorrectal.
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
US8685400B2 (en) 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
ES2408964T3 (es) 2008-07-03 2013-06-24 F. Hoffmann-La Roche Ag ASC como marcador del cáncer de pulmón
WO2012054732A2 (en) * 2010-10-20 2012-04-26 Rush University Medical Center Lung cancer tests
US9725491B2 (en) * 2012-04-24 2017-08-08 Bogazici Universitesi Method for antigen delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911306B1 (en) * 1999-10-18 2005-06-28 Emory University TMS1 compositions and methods of use
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
ES2291750T3 (es) * 2002-12-20 2008-03-01 F. Hoffmann-La Roche Ag Uso de nicotinamida-n-metiltransferasa como marcador de cancer colorrectal.
ES2271892T3 (es) * 2003-05-26 2007-04-16 F. Hoffmann-La Roche Ag Uso de la proteina masp como marcador para el cancer colorrectal.
EP1676135B1 (de) * 2003-10-15 2011-11-16 Roche Diagnostics GmbH Verwendung des proteins asc als marker für brustkrebs
ES2323429T3 (es) 2004-12-23 2009-07-15 F. Hoffmann-La Roche Ag Uso de la asc, como marcador para cancer colorrectal.

Also Published As

Publication number Publication date
EP1831696B1 (de) 2009-03-18
JP4673895B2 (ja) 2011-04-20
CA2586654C (en) 2010-10-05
EP1831696A2 (de) 2007-09-12
WO2006066917A3 (en) 2006-08-24
ES2323429T3 (es) 2009-07-15
DE602005013430D1 (de) 2009-04-30
US7846653B2 (en) 2010-12-07
US20090155820A1 (en) 2009-06-18
JP2008523366A (ja) 2008-07-03
CA2586654A1 (en) 2006-06-29
WO2006066917A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE523777T1 (de) System und verfahren zur bestimmung der analytkonzentration mittels zeitaufgelöster amperometrie
EA201070738A1 (ru) Композиции и способы детекции tiab
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE541216T1 (de) Fluoreszenztestverfahren
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
WO2010000467A8 (en) Asc as a marker for lung cancer
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE531822T1 (de) Diagnose von prostatakrebs
ATE394675T1 (de) Verfahren zum nachweis von brustkrebs
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1831696

Country of ref document: EP